Hyperbolic multivariate feature learning in higher-order heterogeneous networks for drug-disease prediction.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39985835.
- Also identified by DOI 10.1016/j.artmed.2025.103090.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
New drug discovery has always been a costly, time-consuming process with a high failure rate. Repurposing existing drugs offers a valuable alternative and reduces the risks associated with developing new drugs. Various experimental methods have been employed to facilitate drug repositioning; however, associations prediction between drugs and diseases through biological experiments is both expensive and time-consuming. Consequently, it is imperative to develop efficient and highly precise computational methods for predicting these associations. Based on this, we propose a drug-disease associations prediction method based on Hyperbolic Multivariate feature Learning in High-order Heterogeneous Networks for Drug-Disease Prediction, called H<sup>3</sup>ML. Our approach begins by mining high-order information from protein-disease and drug-protein networks to construct high-order heterogeneous networks. Subsequently, we employ multivariate feature learning to create hyperbolic representations, and then enhance the features of the heterogeneous network. Finally, we utilize a hyperbolic graph attention network in the hyperbolic space to aggregate neighbor information and perform the final prediction task. In addition, we evaluate the performance of H<sup>3</sup>ML by comparing it with some state-of-the-art methods across different datasets. The case study further validate the effectiveness of H<sup>3</sup>ML. Our implementation will be publicly available at: https://github.com/jianruichen/H-3ML.
Medical subject headings
- Drug Repositioning
- Machine Learning
- Drug Discovery